Anxiety in youth at clinical high risk for psychosis

Early Intervention in Psychiatry

Volumn 11, Issue 6, 2017, Pages 480-487

  McAusland, Laina ^a   Buchy, Lisa ^a   Cadenhead, Kristin S ^b   Cannon, Tyrone D ^c   Cornblatt, Barbara A ^e   Heinssen, Robert ^f   McGlashan, Thomas H ^d   Perkins, Diana O ^g   Seidman, Larry J ^h   Tsuang, Ming T ^b   Walker, Elaine F ⁱ   Woods, Scott W ^d   Bearden, Carrie E ^j   Mathalon, Daniel H ^k   Addington, Jean ^a  

^a UNIVERSITY OF CALGARY   (Canada)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c YALE UNIVERSITY   (United States)

^d YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e ZUCKER HILLSIDE HOSPITAL   (United States)

^f NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

^g UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^h BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

ⁱ EMORY UNIVERSITY   (United States)

^j UNIVERSITY OF CALIFORNIA   (United States)

^k UNIVERSITY OF CALIFORNIA   (United States)

more..

Author keywords

anxiety; clinical high risk; obsessive compulsive disorder; social phobia; suspiciousness

Indexed keywords

ADULT; ANXIETY DISORDER; ARTICLE; CLINICAL ASSESSMENT; CONTROLLED STUDY; CORRELATIONAL STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; FEMALE; HIGH RISK PATIENT; HUMAN; MAJOR CLINICAL STUDY; MALE; MOOD; OBSESSIVE COMPULSIVE DISORDER; PREVALENCE; PRIORITY JOURNAL; PSYCHOSIS; RACE; SELF-RATING ANXIETY SCALE; SOCIAL INTERACTION ANXIETY SCALE; STRUCTURED INTERVIEW; SUSPICIOUSNESS; SYMPTOMATOLOGY; ADOLESCENT; CASE CONTROL STUDY; CLINICAL TRIAL; COMORBIDITY; MULTICENTER STUDY; PRODROMAL SYMPTOM; UNITED STATES; YOUNG ADULT;

ADOLESCENT; ANXIETY DISORDERS; CASE-CONTROL STUDIES; COMORBIDITY; FEMALE; HUMANS; MALE; PRODROMAL SYMPTOMS; PSYCHOTIC DISORDERS; UNITED STATES; YOUNG ADULT;

EID: 85032002160     PISSN: 17517885     EISSN: 17517893     Source Type: Journal    
DOI: 10.1111/eip.12274     Document Type: Article

References (40)

1. Yung AR, McGorry PD. The initial prodrome in psychosis: descriptive and qualitative aspects. Aust N Z J Psychiatry 1996; 30: 587–599.
2. Achim AM, Maziade M, Raymond E, Olivier D, Mérette C, Roy MA. How prevalent are anxiety disorders in schizophrenia? A meta-analysis and critical review on a significant association. Schizophr Bull 2011; 37: 811–821.
3. Braga RJ, Reynolds GP, Siris SG. Anxiety comorbidity in schizophrenia. Psychiatry Res 2013; 210: 1–7.
4. Hartley S, Barrowclough C, Haddock G. Anxiety and depression in psychosis: a systematic review of associations with positive psychotic symptoms. Acta Psychiatr Scand 2013; 128: 327–346.
5. Huppert JD, Smith TE. Anxiety and schizophrenia: the interaction of subtypes of anxiety and psychotic symptoms. CNS Spectr 2005; 10: 721–731.
6. Fusar-Poli P, Borgwardt S, Bechdolf A et al. The psychosis high-risk state: a comprehensive state-of-the-art review. JAMA Psychiatry 2013; 70: 107–120.
7. Hui C, Morcillo C, Russo DA et al. Psychiatric morbidity, functioning and quality of life in young people at clinical high risk for psychosis. Schizophr Res 2013; 148: 175–180.
8. Meyer SE, Bearden CE, Lux SR et al. The psychosis prodrome in adolescent patients viewed through the lens of DSM-IV. J Child Adolesc Psychopharmacol 2005; 15: 434–451.
9. Woods SW, Addington J, Cadenhead KS et al. Validity of the prodromal risk syndrome for first psychosis: findings from the North American Prodrome Longitudinal Study. Schizophr Bull 2009; 35: 894–908.
10. Stowkowy J, Colijn MA, Addington J. Pathways to care for those at clinical high risk of developing psychosis. Early Interv Psychiatry 2013; 7: 80–83.
11. Addington J, Cornblatt BA, Cadenhead KS et al. At clinical high risk for psychosis: outcome for nonconverters. Am J Psychiatry 2011; 168: 800–805.
12. Conrad AM, Lewin TJ, Sly KA et al. Ten-year audit of clients presenting to a specialised service for young people experiencing or at increased risk for psychosis. BMC Psychiatry 2014; 14: 318.
13. Kelleher I, Murtagh A, Molloy C et al. Identification and characterization of prodromal risk syndromes in young adolescents in the community: a population-based clinical interview study. Schizophr Bull 2012; 38: 239–246.
14. Marshall C, Addington J, Epstein I, Liu L, Deighton S, Zipursky RB. Treating young individuals at clinical high risk for psychosis. Early Interv Psychiatry 2012; 6: 60–68.
15. Salokangas RK, Ruhrmann S, von Reventlow HG et al. Axis I diagnoses and transition to psychosis in clinical high-risk patients EPOS project: prospective follow-up of 245 clinical high-risk outpatients in four countries. Schizophr Res 2012; 138: 192–197.
16. Fusar-Poli P, Nelson B, Valmaggia L, Yung AR, McGuire PK. Comorbid depressive and anxiety disorders in 509 individuals with an at-risk mental state: impact on psychopathology and transition to psychosis. Schizophr Bull 2014; 40: 120–131.
17. Svirskis T, Korkeila J, Heinimaa M et al. Axis-I disorders and vulnerability to psychosis. Schizophr Res 2005; 75: 439–446.
18. Rietdijk J, Ising HK, Dragt S et al. Depression and social anxiety in help-seeking patients with an ultra-high risk for developing psychosis. Psychiatry Res 2013; 209: 309–313.
19. Niendam TA, Berzak J, Cannon TD, Bearden CE. Obsessive compulsive symptoms in the psychosis prodrome: correlates of clinical and functional outcome. Schizophr Res 2009; 108: 170–175.
20. Fontenelle LF, Lin A, Pantelis C, Wood SJ, Nelson B, Yung AR. Markers of vulnerability to obsessive-compulsive disorder in an ultra-high risk sample of patients who developed psychosis. Early Interv Psychiatry 2012; 6: 201–206.
21. Haroun N, Dunn L, Haroun A, Cadenhead KS. Risk and protection in prodromal schizophrenia: ethical implications for clinical practice and future research. Schizophr Bull 2006; 32: 166–178.
22. Lim J, Rekhi G, Rapisarda A et al. Impact of psychiatric comorbidity in individuals at Ultra High Risk of psychosis – Findings from the Longitudinal Youth at Risk Study (LYRIKS). Schizophr Res 2015; 164: 8–14.
23. Schlosser DA, Jacobson S, Chen Q et al. Recovery from an at-risk state: clinical and functional outcomes of putatively prodromal youth who do not develop psychosis. Schizophr Bull 2012; 38: 1225–1233.
24. Swets M, Dekker J, van Emmerik-van Oortmerssen K et al. The obsessive compulsive spectrum in schizophrenia, a meta-analysis and meta-regression exploring prevalence rates. Schizophr Res 2014; 152: 458–468.
25. Cunill R, Castells X, Simeon D. Relationships between obsessive-compulsive symptomatology and severity of psychosis in schizophrenia: a systematic review and meta-analysis. J Clin Psychiatry 2009; 70: 70–82.
26. Berman I, Kalinowski A, Berman SM, Lengua J, Green AI. Obsessive and compulsive symptoms in chronic schizophrenia. Compr Psychiatry 1995; 36: 6–10.
27. Sevincok L, Akoglu A, Kokcu F. Suicidality in schizophrenic patients with and without obsessive-compulsive disorder. Schizophr Res 2007; 90: 198–202.
28. Addington J, Cadenhead KS, Cornblatt BA et al. North American Prodrome Longitudinal Study (NAPLS 2): overview and recruitment. Schizophr Res 2012; 142: 77–82.
29. McGlashan T, Walsh BC, Woods SW. The Psychosis Risk Syndrome: Handbook for Diagnosis and Follow-Up. New York: Oxford University Press, 2010.
30. First M, Spitzer R, Gibbon M, Williams J. Structured Clinical Interview for DSM-IV Axis I Disorders, Clinician Version (SCID-CV). Washington, D.C.: American Psychiatric Press, Inc, 1996.
31. Mattick RP, Clarke JC. Development and validation of measures of social phobia scrutiny fear and social interaction anxiety. Behav Res Ther 1998; 36: 455–470.
32. Zung WW. A rating instrument for anxiety disorders. Psychosomatics 1971; 12: 371–379.
33. Rosen JL, Miller TJ, D'Andrea JT, McGlashan TH, Woods SW. Comorbid diagnoses in patients meeting criteria for the schizophrenia prodrome. Schizophr Res 2006; 85: 124–131.
34. Michail M, Birchwood M. Social anxiety disorder in first-episode psychosis: incidence, phenomenology and relationship with paranoia. Br J Psychiatry 2009; 195: 234–241.
35. Wigman JT, van Nierop M, Vollebergh WA et al. Evidence that psychotic symptoms are prevalent in disorders of anxiety and depression, impacting on illness onset, risk, and severity–implications for diagnosis and ultra-high risk research. Schizophr Bull 2012; 38: 247–257.
36. Corcoran CM, Smith C, McLaughlin D, Auther A, Malaspina D, Cornblatt B. HPA axis function and symptoms in adolescents at clinical high risk for schizophrenia. Schizophr Res 2012; 135: 170–174.
37. Walker EF, Trotman HD, Pearce BD et al. Cortisol levels and risk for psychosis: initial findings from the North American prodrome longitudinal study. Biol Psychiatry 2013; 74: 410–417.
38. Braga RJ, Petrides G, Figueira I. Anxiety disorders in schizophrenia. Compr Psychiatry 2004; 45: 460–468.
39. Addington J, Epstein I, Liu L, French P, Boydell KM, Zipursky RB. A randomized controlled trial of cognitive behavioral therapy for individuals at clinical high risk of psychosis. Schizophr Res 2011; 125: 54–61.
40. Granö N, Karjalainen M, Anto J, Itkonen A, Edlund V, Roine M. Intervention to improve level of overall functioning and mental condition of adolescents at high risk of developing first-episode psychosis in Finland. Early Interv Psychiatry 2009; 3: 94–98.